| Literature DB >> 23044804 |
Shigeo Masuda1, Mo Li, Juan Carlos Izpisua Belmonte.
Abstract
Blood transfusion medicine requires a constant supply of platelets, which is now totally donor dependent. Recent advances in the generation of platelets in vitro through megakaryocytes (MKs) may provide protocols not only via pluripotent stem cells, including induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), but also via induced MKs (iMKs). For the first time, mouse and human fibroblasts are successfully transdifferentiated into iMKs by the introduction of three factors, p45NF-E2, Maf G, and Maf K.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23044804 PMCID: PMC3567822 DOI: 10.1038/cr.2012.142
Source DB: PubMed Journal: Cell Res ISSN: 1001-0602 Impact factor: 25.617